The New Face of Hyperlipidemia Management: Proprotein Convertase Subtilisin/Kexin Inhibitors (PCSK-9) and Their Emergent Role As An Alternative To Statin Therapy.
Lillian L. Smith, Juan F. Mosley, J. Yates, Luke Caswell
Journal of Pharmacy & Pharmaceutical Sciences